Archived Monthly Oncology Tumor Boards - B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas

Archived Monthly Oncology Tumor Boards - B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas

Following this activity, participants should be able to: (1) Identify the risk factors associated with the histologic transformation of indolent B-cell lymphomas. (2) Review evidence from clinical trials supporting the use of novel treatment options for transformed indolent B-cell lymphomas. (3) Develop an individualized treatment plan for patients with transformed indolent B-cell lymphomas.

  • Provider:National Comprehensive Cancer Network
  • Activity Link: https://education.nccn.org/node/95330
  • Start Date: 2024-06-05 05:00:00
  • End Date: 2024-06-05 05:00:00
  • Credit Details: AAPA Category 1 Credit™️: 1.0 hours
    AMA PRA Category 1 Credit™️: 1.0 hours
    Optometry: 1.0 hours
    Pharmacy: 1.0 hours
  • Commercial Support: Source: AstraZeneca (Any division) - Amount: 0.0 - Is Kind Support: False Source: Exelixis - Amount: 0.0 - Is Kind Support: False Source: GlaxoSmithKline - Amount: 0.0 - Is Kind Support: False Source: Lantheus - Amount: 0.0 - Is Kind Support: False Source: Merck (Any division) - Amount: 0.0 - Is Kind Support: False Source: Novartis Corporation Pharmaceuticals - Amount: 0.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.